33 Participants Needed

fMRI for Brain Cancer

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to test the accuracy of using an imaging technique called breath-holding functional magnetic resonance imaging (BH fMRI) in addition to the standard imaging test described above. This study will allow the researchers to find out whether using BH fMRI in combination with the standard approach is the same as, better, or worse than the standard approach used alone.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is fMRI safe for use in brain cancer patients?

fMRI is generally considered safe for use in humans, including brain cancer patients, as it is a noninvasive imaging technique. Studies show that using fMRI for preoperative planning in brain tumor surgeries can reduce the risk of complications after surgery.12345

How is fMRI used as a treatment for brain cancer different from other treatments?

fMRI (functional magnetic resonance imaging) is unique because it helps doctors plan brain surgery by showing which parts of the brain are active and need to be avoided during tumor removal. This is different from other treatments that directly target the tumor, as fMRI is used to protect important brain functions during surgery.16789

What data supports the effectiveness of the treatment fMRI Paradigms for brain cancer?

Research shows that fMRI can help map brain activity in patients with brain tumors, which is useful for planning surgeries to avoid damaging important brain areas. This suggests that fMRI is effective in identifying functional brain regions, potentially preserving brain function during treatment.16101112

Who Is on the Research Team?

AH

Andrei Holodny, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for adults aged 18-80 with brain tumors near areas responsible for speech or movement, who can follow language tasks during an MRI scan. It's not suitable for those with claustrophobia, anxiety preventing MRI exams, pacemakers (unless MRI safe), pregnant/nursing women, and individuals unable to perform required tasks due to physical or cognitive limitations.

Inclusion Criteria

I can follow language tasks as instructed during a scan.
I can follow language tasks as instructed while in a scanner.
I am a woman who can have children and have a negative pregnancy test.
See 3 more

Exclusion Criteria

Volunteers who are unable to comply or complete MRI exams as per the site's standards (e.g.: claustrophobia, high levels of anxiety, pacemaker etc.)
Patients who are unable to comply or complete MRI exams as per the site's standards (e.g.: claustrophobia, high levels of anxiety, pacemaker etc.)
I can follow instructions and perform tasks as asked during a scan.
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Imaging

Participants undergo routine pre-operative MRI including task-based fMRI and perfusion data acquisition, with an additional 5 minutes for breath-holding fMRI (BH fMRI) for research purposes

1 session
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging procedures

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • fMRI Paradigms
Trial Overview The study tests the accuracy of breath-holding fMRI compared to standard imaging in locating brain functions affected by tumors. Researchers aim to determine if this additional imaging technique provides better results than the current standard alone.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Functional Magnetic Resonance Imaging (fMRI)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Weill Medical College of Cornell University

Collaborator

Trials
1,103
Recruited
1,157,000+

Published Research Related to This Trial

A study involving 76 newly diagnosed breast cancer patients and 50 healthy controls found that baseline resting state fMRI can predict cognitive impairments, such as executive dysfunction and memory issues, after chemotherapy treatment.
Patients undergoing chemotherapy experienced a significant increase in executive dysfunction and a decrease in memory function over time, highlighting the potential for early neuroimaging assessments to identify those at risk for cognitive decline and improve patient care.
Predicting Patient Reported Outcomes of Cognitive Function Using Connectome-Based Predictive Modeling in Breast Cancer.Henneghan, AM., Gibbons, C., Harrison, RA., et al.[2021]

Citations

Preoperative blood oxygen level-dependent functional magnetic resonance imaging in patients with primary brain tumors: clinical application and outcome. [2023]
BOLD signal in the motor cortex shows a correlation with the blood volume of brain tumors. [2015]
Functional magnetic resonance imaging of regional brain activity in patients with intracerebral gliomas: findings and implications for clinical management. [2022]
Reliability of Task-Based fMRI for Preoperative Planning: A Test-Retest Study in Brain Tumor Patients and Healthy Controls. [2022]
Characterization of BOLD-fMRI signal during a verbal fluency paradigm in patients with intracerebral tumors affecting the frontal lobe. [2019]
Can Preoperative Mapping with Functional MRI Reduce Morbidity in Brain Tumor Resection? A Systematic Review and Meta-Analysis of 68 Observational Studies. [2021]
Evaluation of a clinical fMRI cueing system utilizing complex scene and auditory stimuli for neurosurgical treatment planning of patients with cognitive and physical deficits. [2015]
Functional MRI studies in non-CNS cancers. [2013]
Predicting Patient Reported Outcomes of Cognitive Function Using Connectome-Based Predictive Modeling in Breast Cancer. [2021]
Pneumatic artificial muscle-based stimulator for passive functional magnetic resonance imaging sensorimotor mapping in patients with brain tumours. [2021]
BOLD-MRI of breast invasive ductal carcinoma: correlation of R2* value and the expression of HIF-1α. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Functional MRI in Neuro-Oncology: State of the Art and Future Directions. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security